Insider Transactions in Q4 2020 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,313
+7.17%
|
$93,939
$3.34 P/Share
|
|
Dec 04
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
14,015
-5.33%
|
$784,840
$56.73 P/Share
|
|
Dec 04
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,468
+4.86%
|
$148,148
$11.75 P/Share
|
|
Dec 02
2020
|
Mark Ho |
SELL
Payment of exercise price or tax liability
|
Direct |
152
-0.8%
|
$8,360
$55.08 P/Share
|
|
Dec 02
2020
|
Keith Kennedy COO / CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
944
-0.79%
|
$51,920
$55.08 P/Share
|
|
Dec 02
2020
|
John Walter Hanna Jr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
465
-0.63%
|
$25,575
$55.08 P/Share
|
|
Dec 02
2020
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,976
-1.13%
|
$108,680
$55.08 P/Share
|
|
Dec 02
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
540
-0.68%
|
$29,700
$55.08 P/Share
|
|
Nov 12
2020
|
Kevin K Gordon Director |
SELL
Open market or private sale
|
Direct |
10,000
-90.97%
|
$470,000
$47.4 P/Share
|
|
Nov 12
2020
|
Kevin K Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$70,000
$7.39 P/Share
|
|
Nov 11
2020
|
Mark Ho |
SELL
Open market or private sale
|
Direct |
13,875
-42.1%
|
$624,375
$45.0 P/Share
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
BUY
Bona fide gift
|
Indirect |
45,812
+32.35%
|
-
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
SELL
Bona fide gift
|
Direct |
45,812
-11.0%
|
-
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
SELL
Exercise of conversion of derivative security
|
Direct |
20,000
-2.15%
|
$840,000
$42.41 P/Share
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.69%
|
$160,000
$8.86 P/Share
|
|
Nov 06
2020
|
John Walter Hanna Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
21,250
-11.29%
|
$913,750
$43.8 P/Share
|
|
Nov 06
2020
|
John Walter Hanna Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+18.19%
|
$425,000
$20.21 P/Share
|
|
Nov 05
2020
|
John Walter Hanna Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,406
-2.7%
|
$262,646
$41.21 P/Share
|
|
Nov 05
2020
|
John Walter Hanna Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,406
+3.89%
|
$44,842
$7.52 P/Share
|
|
Oct 20
2020
|
Mark Ho |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+18.54%
|
$45,000
$6.45 P/Share
|
|
Oct 19
2020
|
Fred E Cohen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$70,000
$7.6 P/Share
|
|
Oct 08
2020
|
Bonnie H Anderson Director |
SELL
Open market or private sale
|
Direct |
50,000
-18.5%
|
$1,900,000
$38.0 P/Share
|
|
Oct 08
2020
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+15.61%
|
$400,000
$8.86 P/Share
|
|
Oct 06
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
2,500
-3.05%
|
$87,500
$35.21 P/Share
|
|
Oct 06
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.96%
|
$50,000
$20.21 P/Share
|